knowledge -WSS

knowledge

author：hotspot 2025-10-02 18:50:00 - browse：7

Senate Finance Committee Chair Ron Wyden (D-Ore.) Leah Millis/Pool via AP

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies.

The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a drug’s price.

“It’s pretty hard to get 26 votes around here,” Finance Chair Ron Wyden (D-Ore.) said after the vote. “So we’re thrilled.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Merck, Johnson & Johnson CEOs will testify on high drug prices

leisure time

WSS

Lawmakers consider Medicare pay reforms for doctors

Will Ozempic

The explosion of genetic testing requires a new approach

Philips to halt sales of sleep apnea machines in U.S.

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Medicare drug price negotiation legal challenge met with skepticism

focus

knowledge

focus

Anesthesiologist group: stop taking Ozempic before surgery

Venture capital firm's plans to take over Akron hospital face hurdles

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Summit: Michael J. Fox on progress in Parkinson's research

Dobbs anniversary: the lost opportunity of abortion as health care

Will Ozempic

Anesthesiologist group: stop taking Ozempic before surgery

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Alkermes shareholders re

The explosion of genetic testing requires a new approach

explore

The EU Joint Clinical Assessment needs to live up to its promise

Lawmakers consider Medicare pay reforms for doctors

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Senate committee scrutinizes Medicare Advantage brokers

Pharmacists can make shortage drugs, but at what cost?

STAT Summit: How a Chicago ER doctor tackles gun violence

leisure time

knowledge

leisure time

focus